“Blood And Marrow Transplant Clinical Trials Network (Bmt Ctn): Addressing Unanswered Questions”. Biol Blood Marrow Transplant 13. Biol Blood Marrow Transplant: 257-262. http://www.ncbi.nlm.nih.gov/pubmed/17317578.
. 2007. “Developing Materials For Transplant Centers To Share Bmt Ctn Clinical Trial Results With Their Patients: A Pilot Study (Poster).”. In Nci Asco Cancer Trials Accrual Symposium. Nci Asco Cancer Trials Accrual Symposium. Bethesda, MD. http://university.asco.org/CT2010.
. 2010. “Development Of An Accrual Assessment Tool For Bmt Ctn Transplant Trials: A Proactive Approach”. In Nci Asco Cancer Trials Accrual Symposium Poster Session. Nci Asco Cancer Trials Accrual Symposium Poster Session. Bethesda, MD. http://university.asco.org/CT2010.
. 2010. “Maximizing Accrual To Transplant Trials In Multiple Myeloma (Mm): Lessons From The Blood And Marrow Transplant Clinical Trials Network (Bmt Ctn), Eastern Cooperative Oncology Group (Ecog) And Cancer And Leukemia Group B (Calgb) Collaboration (Poster).”. In Nci Asco Cancer Trials Accrual Symposium. Nci Asco Cancer Trials Accrual Symposium. Bethesda, MD.
. 2010. “Peripheral-Blood Stem Cells Versus Bone Marrow From Unrelated Donors”. N Engl J Med 367. N Engl J Med: 1487-1496. http://www.ncbi.nlm.nih.gov/pubmed/23075175.
. 2012.